The Epilepsy Market faces challenges such as high treatment costs, limited access in low-income regions, and the need for continuous patient monitoring. However, opportunities abound in the form of emerging therapies, wearable devices, and AI-powered seizure management solutions. Market players focusing on affordability and accessibility are well-positioned for growth.

Collaborations with research institutions, hospitals, and technology providers are helping companies overcome these challenges. Moreover, increased government support and funding for neurological research provide further opportunities to expand treatment access and improve outcomes. With a focus on innovation and patient-centric approaches, the epilepsy market is poised for robust growth in the coming years.

FAQs
Q1: What are the main challenges in the Epilepsy Market?
High costs, limited access in certain regions, and need for continuous monitoring are key challenges.

Q2: Where are the opportunities in the market?
Opportunities exist in wearable devices, AI solutions, new therapies, and government-supported initiatives.